Sarah Brown
Nurse Practitioner · Pine Bluff, ARNPI 1205009818
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Biotronik Inc. at 29.3% of the total. Among nurse practitioner clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 221 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$1K
- Novartis$560
- Merck$459
- Amgen$361
- Johnson & Johnson$337
- Abbott$335
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,680100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 35 | $1,373 |
| Novartis | 54 | $560 |
| Merck | 23 | $459 |
| Amgen | 23 | $361 |
| Johnson & Johnson | 23 | $337 |
| Abbott | 11 | $335 |
| Siemens Medical Solutions USA, Inc. | 1 | $169 |
| Cardiovascular Systems Inc. | 1 | $125 |
| Lexicon Pharmaceuticals, Inc. | 6 | $114 |
| Boston Scientific | 5 | $113 |
| Baxter Healthcare | 1 | $112 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $105 |
| Shield Therapeutics Inc | 4 | $74 |
| E.r. Squibb & Sons, L.L.C. | 4 | $64 |
| CSL Behring | 3 | $47 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Philips North America LLC | 2 | $39 |
| Boehringer Ingelheim | 2 | $37 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Medtronic | 2 | $30 |
| Pfizer | 2 | $25 |
| Medline Industries LP | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Bayer | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioMonitor$286
- Acticor 7 VR-T DX$252
- Artis zee multi-purpose$169
- Cios Alpha$169
- Protego$148
- MitraClip System$141
- Solia$138
- Rivacor$138
- Edora$138
- Acticor$138
- Diamondback Peripheral$125
- Diamondback Coronary$125
- Hillrom - Cardiac Ambulatory Monitor$112
- Rivacor 7 DR-T$106
How this compares
$4,680 in reported general payments places this provider in the 90th percentile of 697 nurse practitioner providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 451 | $390,308 |
| XareltoRivaroxaban | 411 | $346,986 |
| EliquisApixaban | 138 | $131,091 |
| FarxigaDapagliflozin Propanediol | 183 | $130,761 |
| JardianceEmpagliflozin | 87 | $67,827 |
| Repatha SureclickEvolocumab | 48 | $56,230 |
| MultaqDronedarone Hcl | 50 | $50,262 |
| Repatha SyringeEvolocumab | 27 | $20,191 |
| BrilintaTicagrelor | 24 | $14,870 |
| Praluent PenAlirocumab | 11 | $9,746 |
| Nebivolol Hcl | 207 | $8,721 |
| Rosuvastatin Calcium | 826 | $6,574 |
| Ranolazine ErRanolazine | 94 | $6,459 |
| ClopidogrelClopidogrel Bisulfate | 787 | $5,987 |
| Potassium Chloride | 302 | $4,481 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $560 | $390,308451 claims |
| Johnson & JohnsonXarelto | $337 | $346,986411 claims |
| AstraZenecaFarxiga, Brilinta | $15 | $145,632207 claims |
| PfizerEliquis | $25 | $131,091138 claims |
| Boehringer IngelheimJardiance | $37 | $67,82787 claims |
| Sanofi-aventis U.S. LLCMultaq | $23 | $50,26250 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 697 nurse practitioner providers in Arkansas.
Other nurse practitioner in Pine Bluff
- Jena ShepherdPine Bluff$6K
- Jo BlasengamePine Bluff$6K
- Melissa KooncePine Bluff$5K
- Merideth HanksRogers$157K
- Angela JonesJonesboro$90K
- Tiffany McConathyHot Springs$54K
- Brenna FitzgeraldNorth Little Rock$46K
- Iris KennedyLittle Rock$22K
- Virginia LaliberteHot Springs$21K
- Julia PonderLittle Rock$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.